98360609

Information

• Trademark
• 98360609

• Source

• Serial Number

  98360609

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  January 17, 2024
  11 months ago

• Transaction Date

  September 27, 2024
  3 months ago

• Status Date

  August 15, 2024
  4 months ago

• Location Date

  August 15, 2024
  4 months ago

• Status Code

  658

• Current Location

  TMEG LAW OFFICE 101

  Employee Name

  CHUO, EMILY

• Attorney Docket Number

  NEUB 2401453

  Attorney Name

  Allison Strickland Ricketts

  Law Office Assigned Location Code

  L10

• Owners

  • Neurocrine Biosciences, Inc.

Case File Statements

• DM0000: The mark consists of four lines with curved top and bottom edges that become progressively larger from left to right and form the overall shape of a conical seashell.
• GS0051: pharmaceutical preparations for human use; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions
• CC0000: Color is not claimed as a feature of the mark.
• GS0441: Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
• GS0421: providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results

Case File Event Statements

• 1/17/2024 - 11 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 5/5/2024 - 8 months ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 5/5/2024 - 8 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/22/2024 - 7 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 5/30/2024 - 7 months ago

  5 - PRIORITY ACTION WRITTEN Type: CPRA

• 5/30/2024 - 7 months ago

  7 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 5/30/2024 - 7 months ago

  6 - PRIORITY ACTION E-MAILED Type: GPRA

• 7/31/2024 - 5 months ago

  9 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG

• 7/31/2024 - 5 months ago

  8 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 8/15/2024 - 4 months ago

  10 - PRIORITY ACTION WRITTEN Type: CPRA

• 8/15/2024 - 4 months ago

  12 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 8/15/2024 - 4 months ago

  11 - PRIORITY ACTION E-MAILED Type: GPRA

• 8/27/2024 - 4 months ago

  13 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR

• 8/27/2024 - 4 months ago

  14 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG